Progyny, Inc. (PGNY) Stock Price & Analysis
Progyny, Inc. (PGNY) fell 2.52% to USD 25.94 as of September 8, 2026 at 09:37 UTC, according to Nexqual real-time market data.
PGNY last closed at USD 25.94; the session ranged USD 25.82–26.67 on volume of 1,057,015 shares. Market capitalization is —, with a 52-week range of USD 16.1–33.07 (NMS). Source: Nexqual, September 8, 2026 at 09:37 UTC.
Key Statistics (as of September 8, 2026 at 09:37 UTC)
| Price | USD 25.94 |
|---|---|
| Change | ▼ 2.52% (down) |
| Previous Close | USD 25.94 |
| Open | USD 25.94 |
| Day Range | USD 25.82 – 26.67 |
| 52-Week Range | USD 16.1 – 33.07 |
| Volume | 1,057,015 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PGNY)
Nexqual's technical model rates PGNY "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:37 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.51 (neutral) |
| vs SMA50 | Below (USD 28.93) |
| MACD | -0.76 (negative) |
From Progyny, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Our cybersecurity risk management program incorporates industry-standard frameworks, policies and practices designed to protect the security of our technology infrastructure and sensitive information.
Partnerships
- We have experienced and may in the future experience fluctuations in our financial results, making it difficult to project future results, and if we fail to meet the expectations of securities analysts or investors with respect to our results of operations, our stock price and the value of your investment could decline.
- Share Repurchase Program On November 5, 2025, the Company announced the November 2025 share repurchase program (the "November 2025 share repurchase program") of up to $200 million of shares of common stock.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INMD | InMode Ltd. | USD 14.91 | ▼ 0.27% |
| SPT | Sprout Social, Inc | USD 11.36 | ▲ 0.18% |
| OM | Outset Medical, Inc. | USD 3.59 | ▼ 2.18% |
| TXG | 10x Genomics, Inc. | USD 62.65 | ▲ 1.62% |
| HCAT | Health Catalyst, Inc | USD 1.69 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:37 UTC. This page is informational and not investment advice.